Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cilostazol uncovers covert atrial fibrillation in non-cardioembolic stroke.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS investigators. Aoki J, et al. Among authors: yamamoto y, yamamoto n. J Neurol Sci. 2020 Jun 15;413:116796. doi: 10.1016/j.jns.2020.116796. Epub 2020 Mar 21. J Neurol Sci. 2020. PMID: 32222589 Clinical Trial.
Analysis of Factors Associated with Progression and Long-Term Outcomes of Penetrating Artery Territory Infarction: A Retrospective Study.
Takeuchi M, Miyashita K, Nakagawara J, Toyoda K, Todo K, Metoki N, Suzuki R, Manabe Y, Akaiwa Y, Yamamoto Y, Nagatsuka K. Takeuchi M, et al. Among authors: yamamoto y. J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1952-9. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.007. Epub 2016 May 16. J Stroke Cerebrovasc Dis. 2016. PMID: 27199201
Blood biomarkers associated with neurological deterioration in patients with acute penetrating artery territory infarction: A multicenter prospective observational study.
Kawano T, Miyashita K, Takeuchi M, Nagakane Y, Yamamoto Y, Kamiyama K, Manabe Y, Todo K, Metoki N, Akaiwa Y, Toyoda K, Nagatsuka K. Kawano T, et al. Among authors: yamamoto y. Int J Stroke. 2018 Feb;13(2):207-216. doi: 10.1177/1747493016677982. Epub 2016 Nov 2. Int J Stroke. 2018. PMID: 27807280
Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke.
Tanaka T, Yamagami H, Ihara M, Miyata T, Miyata S, Hamasaki T, Amano S, Fukuma K, Yamamoto H, Nakagawara J, Furui E, Uchiyama S, Hyun B, Yamamoto Y, Manabe Y, Ito Y, Fukunaga R, Abumiya T, Yasaka M, Kitagawa K, Toyoda K, Nagatsuka K. Tanaka T, et al. Among authors: yamamoto y, yamamoto h. Circ J. 2019 May 24;83(6):1385-1393. doi: 10.1253/circj.CJ-18-1386. Epub 2019 Apr 19. Circ J. 2019. PMID: 31006731 Free article. Clinical Trial.
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS Investigators. Aoki J, et al. Among authors: yamamoto y, yamamoto n. J Am Heart Assoc. 2019 Aug 6;8(15):e012652. doi: 10.1161/JAHA.119.012652. Epub 2019 Jul 26. J Am Heart Assoc. 2019. PMID: 31347430 Free PMC article. Clinical Trial.
Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc Analysis.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K; ADS investigators. Aoki J, et al. Among authors: yamamoto y, yamamoto n. J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105494. doi: 10.1016/j.jstrokecerebrovasdis.2020.105494. Epub 2020 Dec 2. J Stroke Cerebrovasc Dis. 2021. PMID: 33278804
Microbleeds and clinical outcome in acute mild stroke patients treated with antiplatelet therapy: ADS post-hoc analysis.
Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K. Aoki J, et al. Among authors: yamamoto y, yamamoto n. J Clin Neurosci. 2021 Jul;89:216-222. doi: 10.1016/j.jocn.2021.04.028. Epub 2021 May 12. J Clin Neurosci. 2021. PMID: 34119270
Intensive or standard blood pressure control in patients with a history of ischemic stroke: RESPECT post hoc analysis.
Kitagawa K, Arima H, Yamamoto Y, Ueda S, Rakugi H, Kohro T, Yonemoto K, Matsumoto M, Saruta T, Shimada K; Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group. Kitagawa K, et al. Among authors: yamamoto y. Hypertens Res. 2022 Apr;45(4):591-601. doi: 10.1038/s41440-022-00862-y. Epub 2022 Mar 4. Hypertens Res. 2022. PMID: 35241817 Clinical Trial.
11,988 results
You have reached the last available page of results. Please see the User Guide for more information.